← Back to Directory

Cre8 Enterprise Limited (CRE) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Cre8 Enterprise Limited (CRE).

Get it on Google Play Download on Google Play Download on the App Store Download on the App Store

Equity Details

Price & Market Data

Price: $2.22

Daily Change: +$0.02 / 0.90%

Daily Range: $2.21 - $2.35

Market Cap: $4,471,047

Daily Volume: 5,741

Performance Metrics

1 Week: -6.73%

1 Month: 0.66%

3 Months: -8.60%

6 Months: -53.44%

1 Year: -95.24%

YTD: -24.14%

About Cre8 Enterprise Limited (CRE)

Stay informed with Cre8 Enterprise Limited (CRE) market data. Current price: 2.22, daily change: +$0.02 / 0.90%. Market cap: 4,471,047. Performance over 1-month, 3-month, and 1-year.

Company Details

Employees: 91

Sector: Commercial services

Industry: Commercial printing/Forms

Country: Hong Kong

Details

Cre8 Enterprise Limited, through its subsidiaries, engages in the provision of financial printing services in Hong Kong and the People's Republic of China. The company provides concept creation and artwork design, typesetting, proofreading, translation, printing, binding, logistics arrangement, and uploading or making e-submissions for financial reports and compliance documents on the website of the Stock Exchange and media placements. It also offers technological support services; and website design, branding, and content creation services for marketing materials. In addition, the company disseminates and publishes announcements, circulars, financial reports, and industry news feeds through a website under the Cre8IR brand. It offers its services to listed companies, initial public offering applicants, and private companies in the finance and capital markets under the Cre8 brand name. The company was founded in 2006 and is headquartered in Central, Hong Kong. Cre8 Enterprise Limited is a subsidiary of Cre8 Investments Limited.

Selected stocks

Texxon Holding Limited (NPT)

Protalix BioTherapeutics, Inc. (DE) (PLX)

OFS Credit Company, Inc. (OCCI)

Iveda Solutions, Inc. (IVDA)

Aclaris Therapeutics, Inc. (ACRS)